| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2640 | 2021 |
| Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial JE Cortes, DW Kim, HM Kantarjian, TH Brümmendorf, I Dyagil, ... Journal of Clinical Oncology 30 (28), 3486, 2012 | 558 | 2012 |
| Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman, ... Leukemia 32 (3), 606-615, 2018 | 360 | 2018 |
| The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries VS Hoffmann, M Baccarani, J Hasford, D Lindörfer, S Burgstaller, D Sertic, ... Leukemia 29 (6), 1336-1343, 2015 | 277 | 2015 |
| Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation HJ Xie, Ü Yasar, S Lundgren, L Griskevicius, Y Terelius, M Hassan, ... The pharmacogenomics journal 3 (1), 53-61, 2003 | 271 | 2003 |
| Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study K Maneikis, K Šablauskas, U Ringelevičiūtė, V Vaitekėnaitė, ... The Lancet Haematology 8 (8), e583-e592, 2021 | 241 | 2021 |
| Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia WG Wierda, TJ Kipps, J Dürig, L Griskevicius, S Stilgenbauer, J Mayer, ... Blood, The Journal of the American Society of Hematology 117 (24), 6450-6458, 2011 | 159 | 2011 |
| Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol N Toft, H Birgens, J Abrahamsson, P Bernell, L Griškevičius, H Hallböök, ... European journal of haematology 90 (5), 404-412, 2013 | 152 | 2013 |
| Pharmacogenetics of cyclophosphamide in patients with hematological malignancies H Xie, L Griskevicius, L Ståhle, Z Hassan, Ü Yasar, A Rane, U Broberg, ... European journal of pharmaceutical sciences 27 (1), 54-61, 2006 | 140 | 2006 |
| Treatment and outcome of 2904 CML patients from the EUTOS population-based registry VS Hoffmann, M Baccarani, J Hasford, F Castagnetti, F Di Raimondo, ... Leukemia 31 (3), 593-601, 2017 | 119 | 2017 |
| Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study A Hochhaus, G Rosti, NCP Cross, JL Steegmann, P Le Coutre, ... Leukemia 30 (1), 57-64, 2016 | 114 | 2016 |
| Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients A Spyridonidis, M Labopin, BN Savani, R Niittyvuopio, D Blaise, ... Bone marrow transplantation 55 (6), 1114-1125, 2020 | 109 | 2020 |
| Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years CU Rank, N Toft, R Tuckuviene, K Grell, OJ Nielsen, TL Frandsen, ... Blood, The Journal of the American Society of Hematology 131 (22), 2475-2484, 2018 | 103 | 2018 |
| Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes L Griskevicius, Ü Yasar, M Sandberg, M Hidestrand, E Eliasson, ... European journal of clinical pharmacology 59, 103-109, 2003 | 100 | 2003 |
| Myeloablative and immunosuppressive properties of treosulfan in mice F Sjöö, Z Hassan, M Abedi-Valugerdi, L Griskevicius, C Nilsson, ... Experimental hematology 34 (1), 115-121, 2006 | 99 | 2006 |
| XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in … A Engert, L Griskevicius, Y Zyuzgin, H Lubenau, A Del Giglio Leukemia & lymphoma 50 (3), 374-379, 2009 | 85 | 2009 |
| Complying with the European Clinical Trials directive while surviving the administrative pressure–an alternative approach to toxicity registration in a cancer trial TL Frandsen, M Heyman, J Abrahamsson, K Vettenranta, A Åsberg, ... European journal of cancer 50 (2), 251-259, 2014 | 84 | 2014 |
| Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring E Gineikiene, M Stoskus, L Griskevicius The Journal of Molecular Diagnostics 11 (1), 66-74, 2009 | 83 | 2009 |
| The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia M Pfirrmann, RE Clark, W Prejzner, M Lauseker, M Baccarani, S Saussele, ... Leukemia 34 (8), 2138-2149, 2020 | 79 | 2020 |
| Emergence and spread of SARS-CoV-2 lineage B. 1.620 with variant of concern-like mutations and deletions G Dudas, SL Hong, BI Potter, S Calvignac-Spencer, FS Niatou-Singa, ... Nature communications 12 (1), 5769, 2021 | 76 | 2021 |
